Literature DB >> 1331170

Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages.

P D Smith1, S S Saini, M Raffeld, J F Manischewitz, S M Wahl.   

Abstract

Cytomegalovirus (CMV) is a major cause of inflammatory organ disease in immunosuppressed persons. To elucidate the mechanisms of CMV-induced inflammation, we investigated whether tumor necrosis factor-alpha (TNF-alpha) was involved in the pathogenesis of CMV colitis in patients with AIDS. In in situ hybridization experiments, TNF-alpha mRNA was shown to be abundantly present in colonic mucosa from AIDS patients with CMV colitis but not in colonic mucosa from control (AIDS and normal) subjects. The TNF-alpha transcripts, identified in macrophage-like cells containing cytomegalic inclusions, were positively associated with CMV, but not HIV-1, within the mucosa. In in vitro experiments, a patient-derived isolate of CMV, but not HIV-1Ba-L, induced human monocytes to express TNF-alpha mRNA and to release increased levels of TNF-alpha peptide following stimulation. CMV induction of TNF-alpha may play a critical role in CMV-induced inflammation and, since TNF-alpha upregulates expression of HIV-1, offers a mechanism by which CMV could serve as a co-factor for HIV-1 expression without both viruses infecting the same cell.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331170      PMCID: PMC443219          DOI: 10.1172/JCI116035

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus.

Authors:  M G Davis; S C Kenney; J Kamine; J S Pagano; E S Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression.

Authors:  K A Clouse; P B Robbins; B Fernie; J M Ostrove; A S Fauci
Journal:  J Immunol       Date:  1989-07-15       Impact factor: 5.422

3.  HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes.

Authors:  S M Wahl; J B Allen; S Gartner; J M Orenstein; M Popovic; D E Chenoweth; L O Arthur; W L Farrar; L M Wahl
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

4.  Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor.

Authors:  J E Merrill; Y Koyanagi; I S Chen
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

5.  Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

Authors:  T M Folks; K A Clouse; J Justement; A Rabson; E Duh; J H Kehrl; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

6.  Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells.

Authors:  J Taylor-Wiedeman; J G Sissons; L K Borysiewicz; J H Sinclair
Journal:  J Gen Virol       Date:  1991-09       Impact factor: 3.891

7.  Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus.

Authors:  P R Skolnik; B R Kosloff; M S Hirsch
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

Review 8.  Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment.

Authors:  M A Jacobson; J Mills
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

9.  Coxsackievirus B3-induced production of tumor necrosis factor-alpha, IL-1 beta, and IL-6 in human monocytes.

Authors:  A Henke; C Mohr; H Sprenger; C Graebner; A Stelzner; M Nain; D Gemsa
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

10.  Interleukin-6 induced at mucosal surfaces by gram-negative bacterial infection.

Authors:  P de Man; C van Kooten; L Aarden; I Engberg; H Linder; C Svanborg Edén
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

View more
  31 in total

1.  A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2.

Authors:  V S Goldmacher; L M Bartle; A Skaletskaya; C A Dionne; N L Kedersha; C A Vater; J W Han; R J Lutz; S Watanabe; E D Cahir McFarland; E D Kieff; E S Mocarski; T Chittenden
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  Induction of vascular adhesion protein-1 during liver allograft rejection and concomitant cytomegalovirus infection in rats.

Authors:  T Martelius; M Salmi; H Wu; C Bruggeman; K Höckerstedt; S Jalkanen; I Lautenschlager
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 3.  Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.

Authors:  Michael L Freeman; Michael M Lederman; Sara Gianella
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

4.  The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection.

Authors:  S T Yerkovich; S D Olver; J C Lenzo; C D Peacock; P Price
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

5.  Latent cytomegalovirus infection and innate immune function following a 75 km cycling time trial.

Authors:  Emily C P LaVoy; David C Nieman; Dru A Henson; R Andrew Shanely; Amy M Knab; Lynn Cialdella-Kam; Richard J Simpson
Journal:  Eur J Appl Physiol       Date:  2013-08-09       Impact factor: 3.078

6.  Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro.

Authors:  J L Davignon; P Castanié; J A Yorke; N Gautier; D Clément; C Davrinche
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  Endotoxin administration to humans primes alveolar macrophages for increased production of inflammatory mediators.

Authors:  P D Smith; A F Suffredini; J B Allen; L M Wahl; J E Parrillo; S M Wahl
Journal:  J Clin Immunol       Date:  1994-03       Impact factor: 8.317

8.  Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.

Authors:  K B Lemström; J H Bruning; C A Bruggeman; I T Lautenschlager; P J Häyry
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

9.  Murine cytomegalovirus-associated pneumonitis in the lungs free of the virus.

Authors:  K Tanaka; Y Koga; Y Y Lu; X Y Zhang; Y Wang; G Kimura; K Nomoto
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

10.  Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1.

Authors:  S Michelson; J Alcami; S J Kim; D Danielpour; F Bachelerie; L Picard; C Bessia; C Paya; J L Virelizier
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.